UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000000651
Receipt number R000000780
Scientific Title Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
Date of disclosure of the study information 2007/03/23
Last modified on 2012/03/26 12:04:52

No. Disposal Last modified on Item of update
1 Insert 2007/03/23 16:34:04
2 Update 2007/03/27 15:15:39 Recruitment status
3 Update 2007/03/27 15:26:30 Public title
4 Update 2008/06/12 19:30:36 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2008/08/19 16:54:07 UMIN ID1
6 Update 2008/08/19 16:56:07 UMIN ID2
7 Update 2008/08/19 16:56:24 UMIN ID2
8 Update 2008/08/19 17:02:41 Last name of lead principal investigator
Last name of contact person
Name of person sending information
Name of person sending information
Division name
Division name
TEL
Email
9 Update 2009/06/15 10:51:06 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
10 Update 2012/03/26 12:04:52 Publication of results
URL related to results and publications
Results